We are live on ! Find out more
CDIOW icon

Cardio Diagnostics Holdings Inc Warrant

13 hedge funds and large institutions have $295K invested in Cardio Diagnostics Holdings Inc Warrant in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% less funds holding

Funds holding: 1613 (-3)

54% less capital invested

Capital invested by funds: $637K → $295K (-$342K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
5
Closed
3
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

CDIOW Hedge Fund Activity: Q2 2023 in Review

13 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics Holdings Inc Warrant (CDIOW) for Q2 2023, worth a combined $295K — down 54% from $637K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CDIOW and 0 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 0 added.

The largest seller was AQR Arbitrage, exiting entirely with an estimated $5.51K sold.

  • 13 institutional investors held Cardio Diagnostics Holdings Inc Warrant (CDIOW) as of Q2 2023, down from 16 in Q1 2023.
  • Funds reported $295K of Cardio Diagnostics Holdings Inc Warrant stock for Q2 2023, down 54% quarter-over-quarter.
  • 0 funds opened new Cardio Diagnostics Holdings Inc Warrant positions in Q2 2023 and 3 closed out, a net change of -3 holders.
  • The largest Cardio Diagnostics Holdings Inc Warrant seller in Q2 2023 was AQR Arbitrage, an estimated $5.51K sold.

Based on aggregated 13F filings for Q2 2023.